Immix Biopharma Inc
IMMX
Get informed when a big investor buys or sells
+ FollowMarket Cap$680.02M
Close$
$2.82
76.4% downside
Current Fair Value
76.4% downsideOvervalued by 76.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $680.02 Million |
|---|---|
| Enterprise Value | $455.53 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.89 |
| Beta | 0.11 |
| Outstanding Shares | 63,771,377 |
Return
| Return on Equity | -17.44% |
|---|---|
| Return on Assets | -16.69% |
| Return on Invested Capital | -18.11% |
Valuation & Multiples
| P/E Ratio | -14.2 |
|---|---|
| PEG | -19.06 |
| Price to Sales | - |
| Price to Book Ratio | 3.97 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -10.94 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
$-0.21
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 6, 2026
EPS Estimate
$-0.18
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2263▼ 328.90% |
|---|---|
| Total Calls | 97,200▲ 273.85% |
| Total Puts | 22,000▼ 75.93% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 88.36%▲ 39.46% |
|---|---|
| Total Invested | $580.87M▲ 135.54% |
| Investors Holding | 114▲ 35.00% |
ESG Score
No data